Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Resources
White Papers
May 29, 2024
Case Study: Pre-/Post-Implementation; Can Bayesian MIPD enhance target attainment and clinical outcomes for patients receiving vancomycin?
Product Innovation
May 28, 2024
Introducing Apollo Gold: Enhancing Data-Driven Insights and Real-Time Recommendations
Scientific Publications
May 21, 2024
Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity
Scientific Publications
Mar 26, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Scientific Publications
Mar 24, 2024
Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing
Scientific Publications
Mar 15, 2024
Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease
Thought Leadership
Feb 27, 2024
Artificial Intelligence Drives Industry Response to Project Optimus
Thought Leadership
Jan 12, 2024
Improving Hospital Workflows by Integrating a Precision Dosing Platform with EHRs
Scientific Publications
Nov 29, 2023
Thomson model results in higher vancomycin AUC target attainment rates in non-morbidly obese adults
1
2
3
4
5
